149 related articles for article (PubMed ID: 34365595)
1. Association of initial prednisolone dose with remission, relapse, and infectious complications in adult-onset minimal change disease.
Tanabe K; Samejima KI; Fukata F; Kosugi T; Tsushima H; Morimoto K; Okamoto K; Matsui M; Eriguchi M; Maruyama N; Akai Y; Tsuruya K
Clin Exp Nephrol; 2022 Jan; 26(1):29-35. PubMed ID: 34365595
[TBL] [Abstract][Full Text] [Related]
2. Treatment patterns and steroid dose for adult minimal change disease relapses: A retrospective cohort study.
Ozeki T; Ando M; Yamaguchi M; Katsuno T; Kato S; Yasuda Y; Tsuboi N; Maruyama S
PLoS One; 2018; 13(6):e0199228. PubMed ID: 29912938
[TBL] [Abstract][Full Text] [Related]
3. Randomized, Controlled Trial of Tacrolimus and Prednisolone Monotherapy for Adults with
Medjeral-Thomas NR; Lawrence C; Condon M; Sood B; Warwicker P; Brown H; Pattison J; Bhandari S; Barratt J; Turner N; Cook HT; Levy JB; Lightstone L; Pusey C; Galliford J; Cairns TD; Griffith M
Clin J Am Soc Nephrol; 2020 Feb; 15(2):209-218. PubMed ID: 31953303
[TBL] [Abstract][Full Text] [Related]
4. Combined cyclosporine and prednisolone therapy using cyclosporine blood concentration monitoring for adult patients with new-onset minimal change nephrotic syndrome: a single-center pilot randomized trial.
Shirai S; Imai N; Sueki S; Matsui K; Tominaga N; Sakurada T; Yasuda T; Kimura K; Shibagaki Y
Clin Exp Nephrol; 2018 Apr; 22(2):283-290. PubMed ID: 28699032
[TBL] [Abstract][Full Text] [Related]
5. Comparison of methylprednisolone plus prednisolone with prednisolone alone as initial treatment in adult-onset minimal change disease: a retrospective cohort study.
Shinzawa M; Yamamoto R; Nagasawa Y; Oseto S; Mori D; Tomida K; Hayashi T; Izumi M; Fukunaga M; Yamauchi A; Tsubakihara Y; Isaka Y
Clin J Am Soc Nephrol; 2014 Jun; 9(6):1040-8. PubMed ID: 24721890
[TBL] [Abstract][Full Text] [Related]
6. Combined cyclosporine and prednisolone therapy in adult patients with the first relapse of minimal-change nephrotic syndrome.
Eguchi A; Takei T; Yoshida T; Tsuchiya K; Nitta K
Nephrol Dial Transplant; 2010 Jan; 25(1):124-9. PubMed ID: 19740915
[TBL] [Abstract][Full Text] [Related]
7. Short-Term Steroid Regimen for Adult Steroid-Sensitive Minimal Change Disease.
Ozeki T; Katsuno T; Hayashi H; Kato S; Yasuda Y; Ando M; Tsuboi N; Hagiwara D; Arima H; Maruyama S
Am J Nephrol; 2019; 49(1):54-63. PubMed ID: 30557879
[TBL] [Abstract][Full Text] [Related]
8. Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome.
Amemiya N; Takei T; Kojima C; Nokiba H; Itabashi M; Nitta K
Clin Exp Nephrol; 2011 Dec; 15(6):933-6. PubMed ID: 21823044
[TBL] [Abstract][Full Text] [Related]
9. Retrospective single-arm cohort study of steroid-dependent minimal change nephrotic syndrome treated with very low-dose rituximab.
Fujimoto K; Kagaya Y; Kumano S; Fujii A; Tsuruyama Y; Matsuura T; Yamazaki K; Nomura K; Okada K; Okino K; Adachi H; Furuichi K; Yokoyama H
Clin Nephrol; 2021 Jan; 95(1):29-36. PubMed ID: 33074094
[TBL] [Abstract][Full Text] [Related]
10. Favorable outcome of low-dose cyclosporine after pulse methylprednisolone in Japanese adult minimal-change nephrotic syndrome.
Matsumoto H; Nakao T; Okada T; Nagaoka Y; Takeguchi F; Tomaru R; Iwasawa H
Intern Med; 2004 Aug; 43(8):668-73. PubMed ID: 15468963
[TBL] [Abstract][Full Text] [Related]
11. Insufficient Use of Corticosteroids without Immunosuppressants Results in Higher Relapse Rates in Takayasu Arteritis.
Mutoh T; Shirai T; Fujii H; Ishii T; Harigae H
J Rheumatol; 2020 Feb; 47(2):255-263. PubMed ID: 31092708
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Efficacy and Safety of Tacrolimus and Low-Dose Corticosteroid with High-Dose Corticosteroid for Minimal Change Nephrotic Syndrome in Adults.
Chin HJ; Chae DW; Kim YC; An WS; Ihm C; Jin DC; Kim SG; Kim YL; Kim YS; Kim YG; Koo HS; Lee JE; Lee KW; Oh J; Park JH; Jiang H; Lee H; Lee SK
J Am Soc Nephrol; 2021 Jan; 32(1):199-210. PubMed ID: 33168602
[TBL] [Abstract][Full Text] [Related]
13. [Combined effect of cyclosporin and prednisolone for minimal change nephrotic syndrome: comparison with prednisolone therapy].
Hayashi M; Kimura N; Fukatsu A
Nihon Jinzo Gakkai Shi; 2008; 50(5):581-7. PubMed ID: 18767486
[TBL] [Abstract][Full Text] [Related]
14. Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy Network.
Chen DP; Helmuth ME; Smith AR; Canetta PA; Ayoub I; Mucha K; Kallash M; Kopp JB; Gbadegesin R; Gillespie BW; Greenbaum LA; Parekh RS; Hunley TE; Sperati CJ; Selewski DT; Kidd J; Chishti A; Reidy K; Mottl AK; Gipson DS; Srivastava T; Twombley KE;
Am J Kidney Dis; 2023 Jun; 81(6):695-706.e1. PubMed ID: 36608921
[TBL] [Abstract][Full Text] [Related]
15. Low-dose corticosteroid and mycophenolate for primary treatment of minimal change disease.
Ma MKM; Yap DYH; Li CL; Mok MMY; Chan GCW; Kwan LPY; Lai KN; Tang SCW
QJM; 2020 Jun; 113(6):399-403. PubMed ID: 31769845
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of leflunomide in treatment of steroid-dependent and steroid-resistant adult onset minimal change disease.
Zhou J; Zhang Y; Liu G; Li J; Xu R; Huang J
Clin Nephrol; 2013 Aug; 80(2):121-9. PubMed ID: 23458173
[TBL] [Abstract][Full Text] [Related]
17. Minimal change nephrotic syndrome in adults: response to corticosteroid therapy and frequency of relapse.
Fujimoto S; Yamamoto Y; Hisanaga S; Morita S; Eto T; Tanaka K
Am J Kidney Dis; 1991 Jun; 17(6):687-92. PubMed ID: 2042651
[TBL] [Abstract][Full Text] [Related]
18. Adult minimal-change disease: observational data from a UK centre on patient characteristics, therapies, and outcomes.
Fenton A; Smith SW; Hewins P
BMC Nephrol; 2018 Aug; 19(1):207. PubMed ID: 30115013
[TBL] [Abstract][Full Text] [Related]
19. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
Maas RJ; Deegens JK; Beukhof JR; Reichert LJ; Ten Dam MA; Beutler JJ; van den Wall Bake AWL; Rensma PL; Konings CJ; Geerse DA; Feith GW; Van Kuijk WH; Wetzels JF
Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of repeat-dose rituximab maintenance therapy for minimal change disease in adults.
Taguchi S; Ohtake T; Mochida Y; Ishioka K; Moriya H; Hidaka S; Kobayashi S
Clin Exp Nephrol; 2020 Dec; 24(12):1132-1139. PubMed ID: 32761467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
